Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.87B |
| 2 |
NVIDIA
NVDA
|
+$358M |
| 3 |
Suncor Energy
SU
|
+$287M |
| 4 |
Microsoft
MSFT
|
+$278M |
| 5 |
Apple
AAPL
|
+$200M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.8B |
| 2 |
Canadian Natural Resources
CNQ
|
+$205M |
| 3 |
Intuit
INTU
|
+$177M |
| 4 |
Adobe
ADBE
|
+$120M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$95.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.4% |
| 2 | Financials | 18.68% |
| 3 | Industrials | 9.33% |
| 4 | Healthcare | 8.68% |
| 5 | Communication Services | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Celldex Therapeutics
CLDX
$3.28B
| $24M | 0.01% |
927,157
+104,949
| +13% | +$2.43M |
|
302
Denali Therapeutics
DNLI
$3.89B
| $23.7M | 0.01% |
1,631,496
+115,505
| +8% | +$1.66M |
|
303
Tetra Tech
TTEK
$9.05B
| $23.7M | 0.01% |
709,366
-16,258
| -2% | -$591K |
|
304
Patterson-UTI
PTEN
$3.87B
| $23.7M | 0.01% |
4,566,801
-142,814
| -3% | -$821K |
|
305
Dr. Reddy's Laboratories
RDY
$10.2B
| $23.5M | 0.01% |
1,681,411
-338,104
| -17% | -$4.87M |
|
306
IDEAYA Biosciences
IDYA
$3.51B
| $23.5M | 0.01% |
862,208
-59,884
| -6% | -$1.45M |
|
307
HubSpot
HUBS
$10.3B
| $23.5M | 0.01% |
50,149
-1,326
| -3% | -$667K |
|
308
Cactus
WHD
$5.44B
| $23.4M | 0.01% |
593,696
+67,425
| +13% | +$2.84M |
|
309
PTC
PTC
$16B
| $23.3M | 0.01% |
114,766
+22,139
| +24% | +$4.51M |
|
310
UFP Industries
UFPI
$5.13B
| $23.1M | 0.01% |
247,329
-9,381
| -4% | -$947K |
|
311
Medtronic
MDT
$110B
| $22.8M | 0.01% |
239,529
-34,537
| -13% | -$3.17M |
|
312
Vanguard Total World Stock ETF
VT
$79.7B
| $22.6M | 0.01% |
163,995
+12,223
| +8% | +$1.62M |
|
313
Cisco
CSCO
$478B
| $22.6M | 0.01% |
329,668
+100,293
| +44% | +$6.84M |
|
314
SM Energy
SM
$7.03B
| $22.4M | 0.01% |
896,332
+35,031
| +4% | +$945K |
|
315
Hancock Whitney
HWC
$6.24B
| $21.9M | 0.01% |
348,993
+72,433
| +26% | +$4.44M |
|
316
RLJ Lodging Trust
RLJ
$1.75B
| $21.8M | 0.01% |
3,033,121
-23,835
| -0.8% | -$180K |
|
317
Box
BOX
$4.54B
| $21.4M | 0.01% |
663,281
+288
| +0% | +$9.32K |
|
318
F5
FFIV
$23.1B
| $20.9M | 0.01% |
64,771
+12,023
| +23% | +$3.76M |
|
319
Cal-Maine
CALM
$4B
| $20.8M | 0.01% |
220,781
+11,127
| +5% | +$1.19M |
|
320
Moog Inc Class A
MOG.A
$12.8B
| $20.5M | 0.01% |
98,728
+1,077
| +1% | +$208K |
|
321
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.54B
| $20.1M | 0.01% |
324,186
-15,705
| -5% | -$943K |
|
322
BioCryst Pharmaceuticals
BCRX
$2.44B
| $20M | 0.01% |
2,632,696
-149,793
| -5% | -$1.25M |
|
323
Scholar Rock
SRRK
$6.22B
| $19.9M | 0.01% |
533,176
+120,765
| +29% | +$4.22M |
|
324
Independence Realty Trust
IRT
$4.06B
| $19.7M | 0.01% |
1,202,187
-111,739
| -9% | -$1.94M |
|
325
SiteOne Landscape Supply
SITE
$4.56B
| $19.7M | 0.01% |
152,865
+20,095
| +15% | +$2.73M |
|
Similar funds
Ken Fisher's Q3 2025 Portfolio in Review
As of Q3 2025, Ken Fisher held 1,094 positions worth $276B, up 9.7% from $252B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher's Q3 2025 filing shows 108 new, 450 increased, 424 reduced and 80 closed positions. Its largest new stake was Sanmina: 166,861 shares worth $19.2M. The largest sale was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Ken Fisher's largest Q3 2025 buy was Sanmina: 166,861 shares worth $19.2M.
- Ken Fisher added most to iShares 7-10 Year Treasury Bond ETF in Q3 2025, an estimated $2.87B increase.
- Ken Fisher's biggest Q3 2025 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $1.8B.
- Ken Fisher fully exited WEX in Q3 2025, selling an estimated $14.2M.
- Ken Fisher's ten largest holdings make up 32% of its $276B portfolio in Q3 2025.
- Ken Fisher opened 108 new positions and closed 80 in Q3 2025.
- Ken Fisher's portfolio value rose 9.7% quarter-over-quarter to $276B.
Based on Fisher Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.